Marker Therapeutics Inc (MRKR)

[poods]

You're correct but sometimes something as simple as saying "we hope to present data showing signs of real activity in pancreatic cancer" can send a stock soaring. It did for MRKR a couple of months ago.
CEO could say "we're continuing to see compelling evidence of activity in pancreatic cancer" (or another solid tumor) that we plan to present in an upcoming conference.
I'm just speculating and likely there's nothing new driving this, but I can't be certain. The timing is interesting.